-
Heska To $165? Plus BTIG Cuts PT On This Stock By 67%
Monday, November 14, 2022 - 9:21am | 351BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ: GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at $3.21 on Friday. Piper Sandler cut the price target for Heska Corporation (NASDAQ: HSKA) from $...
-
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Monday, November 14, 2022 - 3:35am | 3108Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. Shares of several companies in the broader industrial space traded higher on continued hopes of softer Fed policy after CPI this week showed October inflation below estimates. Exela Technologies, Inc. (...
-
Flowers Foods, EverCommerce, And Some Other Big Stocks Moving Lower On Friday
Friday, November 11, 2022 - 12:12pm | 461U.S. stocks traded mixed, with the Nasdaq gaining more than 100 points on Friday. Here are some big stocks recording losses in today’s session. Expensify, Inc. (NASDAQ: EXFY) dropped 19.2% to $10.46 after the company reported worse-than-expected Q3 EPS and sales results. Ryan Specialty...
-
All Is Calm Ahead Of The Federal Reserve This Afternoon
Wednesday, November 2, 2022 - 1:19pm | 1433Good Morning Everyone! Remember, today at 2pm, a group of middle-aged financial experts determines whether or not millions of Robinhood traders get margin called. Prices as of 4 pm EST, 11/1/22; % YTD MARKET UPDATE 2 p.m. Fed Reserve Rate decision Volatility is relatively LOW heading...
-
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
Wednesday, November 2, 2022 - 7:58am | 1269Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 28.8% to $23.55 in pre-market trading. Arcturus...
-
McKesson To $440? Plus This Analyst Raises PT On Fox
Wednesday, November 2, 2022 - 7:26am | 274Baird boosted the price target on McKesson Corporation (NYSE: MCK) from $405 to $440. McKesson shares fell 1.7% to $375.55 in pre-market trading. Rosenblatt raised Fox Corporation (NASDAQ: FOXA) price target from $30 to $31. Fox shares gained 5.8% to close at $30.53 on Tuesday. Raymond...
-
Weibo, XPeng, Li Auto And Other Big Losers From Friday
Monday, October 31, 2022 - 5:44am | 868U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. DaVita Inc. (NYSE: DVA) shares dipped 27.1% to close at $70.54 after the company reported worse-than-expected Q3 EPS and sales results...
-
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Monday, October 31, 2022 - 4:13am | 2370Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) surged 61.4% to close at $0.92 after jumping 15% on Thursday. Nuvalent, Inc. (NASDAQ: NUVL) shares gained 60.6% to close at $35.34 after the company reported...
-
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Friday, October 28, 2022 - 12:12pm | 1645Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301. Nuvalent, Inc. (NASDAQ: NUVL) shares jumped 62% to $35.60 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive...
-
Labcorp Forecasts Steeper Fall In COVID-19 Testing Sales
Thursday, October 27, 2022 - 1:16pm | 238Laboratory Corp of America Holdings (NYSE: LH) posted Q3 revenues of $3.61 billion, a decrease of 11.2% Y/Y, missing the consensus of $3.79 billion. The 10.7% decrease in organic revenue was driven by an 11.8% decrease in COVID-19 Testing, partially offset by a 1.1% increase in the...
-
ZoomInfo Technologies, McKesson And This Restaurant Stock Insiders Are Selling
Thursday, October 13, 2022 - 9:23am | 523US crude oil futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity...
-
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Tuesday, October 11, 2022 - 2:17am | 2283Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. Immunic, Inc. (NASDAQ: IMUX) jumped 56.6% to close at $6.20 after...
-
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
Monday, October 10, 2022 - 11:59am | 1650Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the mid-six-figures. Immunic, Inc. (NASDAQ: IMUX) surged 43.5% to $5.70 after the company announced $60...
-
Insiders Selling AutoNation, Hershey And This Healthcare Stock
Thursday, September 29, 2022 - 8:53am | 558Gold futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go...
-
Moleculin Biotech's Potential Antiviral Compound Selected For NIAID-Funded Animal Studies
Tuesday, September 27, 2022 - 1:01pm | 288Moleculin Biotech Inc (NASDAQ: MBRX) announced that its WP1096 molecule would be evaluated in animal studies by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Moleculin studies WP1096 as a novel potential therapy...